vs

Side-by-side financial comparison of PUMA BIOTECHNOLOGY, INC. (PBYI) and SMARTFINANCIAL INC. (SMBK). Click either name above to swap in a different company.

PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $53.8M, roughly 1.4× SMARTFINANCIAL INC.). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 15.4%).

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

SmartFinancial Inc. is a U.S.-based bank holding company that operates its wholly owned subsidiary SmartBank. It offers a full range of retail and commercial banking products including deposit accounts, personal and business loans, mortgage services, and wealth management solutions, primarily serving individual customers and small-to-medium enterprises across the Southeastern United States.

PBYI vs SMBK — Head-to-Head

Bigger by revenue
PBYI
PBYI
1.4× larger
PBYI
$75.5M
$53.8M
SMBK
Faster 2-yr revenue CAGR
PBYI
PBYI
Annualised
PBYI
31.3%
15.4%
SMBK

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
PBYI
PBYI
SMBK
SMBK
Revenue
$75.5M
$53.8M
Net Profit
$13.7M
Gross Margin
69.3%
Operating Margin
22.7%
Net Margin
25.4%
Revenue YoY
27.7%
Net Profit YoY
21.6%
EPS (diluted)
$0.26
$0.81

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PBYI
PBYI
SMBK
SMBK
Q1 26
$53.8M
Q4 25
$75.5M
$53.3M
Q3 25
$54.5M
$51.1M
Q2 25
$52.4M
$49.2M
Q1 25
$46.0M
$46.8M
Q4 24
$59.1M
$46.8M
Q3 24
$80.5M
$44.2M
Q2 24
$47.1M
$40.4M
Net Profit
PBYI
PBYI
SMBK
SMBK
Q1 26
$13.7M
Q4 25
$13.7M
Q3 25
$8.8M
$13.7M
Q2 25
$5.9M
$11.7M
Q1 25
$3.0M
$11.3M
Q4 24
$9.6M
Q3 24
$20.3M
$9.1M
Q2 24
$-4.5M
$8.0M
Gross Margin
PBYI
PBYI
SMBK
SMBK
Q1 26
Q4 25
69.3%
Q3 25
77.7%
Q2 25
76.5%
Q1 25
77.1%
Q4 24
76.4%
Q3 24
63.9%
Q2 24
77.4%
Operating Margin
PBYI
PBYI
SMBK
SMBK
Q1 26
Q4 25
22.7%
31.3%
Q3 25
17.6%
33.2%
Q2 25
12.7%
29.0%
Q1 25
8.7%
29.0%
Q4 24
22.6%
26.5%
Q3 24
27.4%
24.3%
Q2 24
-4.6%
25.6%
Net Margin
PBYI
PBYI
SMBK
SMBK
Q1 26
25.4%
Q4 25
25.7%
Q3 25
16.2%
26.8%
Q2 25
11.2%
23.8%
Q1 25
6.5%
24.0%
Q4 24
20.6%
Q3 24
25.2%
20.7%
Q2 24
-9.6%
19.8%
EPS (diluted)
PBYI
PBYI
SMBK
SMBK
Q1 26
$0.81
Q4 25
$0.26
$0.81
Q3 25
$0.17
$0.81
Q2 25
$0.12
$0.69
Q1 25
$0.06
$0.67
Q4 24
$0.40
$0.57
Q3 24
$0.41
$0.54
Q2 24
$-0.09
$0.48

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PBYI
PBYI
SMBK
SMBK
Cash + ST InvestmentsLiquidity on hand
$97.5M
$346.1M
Total DebtLower is stronger
$22.7M
Stockholders' EquityBook value
$130.3M
$562.2M
Total Assets
$216.3M
$5.9B
Debt / EquityLower = less leverage
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PBYI
PBYI
SMBK
SMBK
Q1 26
$346.1M
Q4 25
$97.5M
$464.4M
Q3 25
$94.4M
$557.1M
Q2 25
$96.0M
$365.1M
Q1 25
$93.2M
$423.0M
Q4 24
$101.0M
$387.6M
Q3 24
$96.7M
$192.9M
Q2 24
$96.8M
$342.8M
Total Debt
PBYI
PBYI
SMBK
SMBK
Q1 26
Q4 25
$22.7M
Q3 25
$34.0M
$1.3M
Q2 25
$45.3M
$7.0M
Q1 25
$56.7M
$7.6M
Q4 24
$68.0M
$8.1M
Q3 24
$79.3M
$9.0M
Q2 24
$90.7M
$12.7M
Stockholders' Equity
PBYI
PBYI
SMBK
SMBK
Q1 26
$562.2M
Q4 25
$130.3M
$552.4M
Q3 25
$115.3M
$538.4M
Q2 25
$104.7M
$519.0M
Q1 25
$97.1M
$505.8M
Q4 24
$92.1M
$491.3M
Q3 24
$71.1M
$489.0M
Q2 24
$48.5M
$472.5M
Total Assets
PBYI
PBYI
SMBK
SMBK
Q1 26
$5.9B
Q4 25
$216.3M
$5.9B
Q3 25
$202.9M
$5.8B
Q2 25
$194.9M
$5.5B
Q1 25
$196.2M
$5.4B
Q4 24
$213.3M
$5.3B
Q3 24
$220.7M
$4.9B
Q2 24
$205.0M
$4.9B
Debt / Equity
PBYI
PBYI
SMBK
SMBK
Q1 26
Q4 25
0.17×
Q3 25
0.30×
0.00×
Q2 25
0.43×
0.01×
Q1 25
0.58×
0.02×
Q4 24
0.74×
0.02×
Q3 24
1.12×
0.02×
Q2 24
1.87×
0.03×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PBYI
PBYI
SMBK
SMBK
Operating Cash FlowLast quarter
$14.4M
Free Cash FlowOCF − Capex
$14.4M
FCF MarginFCF / Revenue
19.1%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$41.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PBYI
PBYI
SMBK
SMBK
Q1 26
Q4 25
$14.4M
$61.7M
Q3 25
$9.7M
$16.9M
Q2 25
$14.1M
$14.0M
Q1 25
$3.6M
$14.3M
Q4 24
$15.6M
$52.7M
Q3 24
$11.0M
$12.4M
Q2 24
$1.0M
$16.5M
Free Cash Flow
PBYI
PBYI
SMBK
SMBK
Q1 26
Q4 25
$14.4M
$59.3M
Q3 25
$9.7M
$16.6M
Q2 25
$14.1M
$13.2M
Q1 25
$3.6M
$13.4M
Q4 24
$15.6M
$46.3M
Q3 24
$11.0M
$11.3M
Q2 24
$1.0M
$15.4M
FCF Margin
PBYI
PBYI
SMBK
SMBK
Q1 26
Q4 25
19.1%
111.3%
Q3 25
17.7%
32.4%
Q2 25
26.8%
26.9%
Q1 25
7.7%
28.5%
Q4 24
26.4%
98.9%
Q3 24
13.7%
25.7%
Q2 24
2.1%
38.2%
Capex Intensity
PBYI
PBYI
SMBK
SMBK
Q1 26
Q4 25
0.0%
4.5%
Q3 25
0.0%
0.6%
Q2 25
0.0%
1.6%
Q1 25
0.1%
2.0%
Q4 24
0.0%
13.7%
Q3 24
0.0%
2.4%
Q2 24
0.0%
2.7%
Cash Conversion
PBYI
PBYI
SMBK
SMBK
Q1 26
Q4 25
4.50×
Q3 25
1.10×
1.23×
Q2 25
2.41×
1.20×
Q1 25
1.21×
1.27×
Q4 24
5.47×
Q3 24
0.54×
1.36×
Q2 24
2.07×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PBYI
PBYI

Segment breakdown not available.

SMBK
SMBK

Net Interest Income$45.9M85%
Noninterest Income$7.9M15%

Related Comparisons